Jae Ryong Song, Un Chul Park, Christopher Seungkyu Lee, Jae Jin Cho, Jin Young Kim, Seung Chul Baek, Areum Jeong, Ashish Sharma, Jae Hui Kim, Min Sagong, Se Joon Woo, Baruch D. Kuppermann, Anat Loewenstein, Francesco Bandello, Carl D. Regillo, Luke Nicholson, Clara Vazquez-Alfageme, Nilesh Kumar, Nikulaa Parachuri, Seemantini Ayachit, Alay Banker, Kourous A. Rezaei, Arshad M. Khanani, Peter K. Kaiser, Frank G. Holz, Sobha Sivaprasad, Taku Wakabayashi, Giuseppe Querques, Şengül Özdek, Kodjikian Laurent, Alper Bilgic, Paolo Lanzetta, Caroline R. Baumal, Nancy Holekemp, Taiji Sakamoto, Adnan Tufail, Nicolas Yannuzzi, Giulia Corradetti, Jay Sheth, Chitaranjan Mishra, Debdulal Chakraborty, David Boyer, Aleksandra Rachitskaya, Tunde Peto, Maximilian W. M. Wintergerst, Valentina Sarao, Barbara Parolini, Khalil Ghasemi Falavarjani, Quan Dong Nguyen, Diana V. Do, Pearse A. Keane, Tarek Hassan, Jayanth Sridhar, David Eichenbaum, Dilraj S. Grewal, Francesc March, Martin Spitzer, Martin S. Zinkernagel, Tomoko Ueda-Consolvo, Masaaki Ishida, Tomoko Nakamura, Shuichiro Yanagisawa, Kotaro Tsuboi, Atsushi Hayashi, Judy Kim. "Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea Study." Scientific Reports, 2026. doi:10.1038/s41598-025-34325-4